Congenital Hematological Disorder Enrolling by Invitation Phase Trials for Catridecacog (DB09310)
Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder
| Indication | Status | Phase |
|---|---|---|
| DBCOND0081791 (Congenital Hematological Disorder) | Enrolling by Invitation | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02670213 | A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan |